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Abstract: The presented study is focused on the generation of osteochondral implants for cartilage repair, which consist 
of bone substitutes covered with in vitro engineered cartilage. Re-differentiation of expanded porcine cells was performed 
in alginate gel followed by cartilage formation in high-density cell cultures. In this work, different combinations of growth 
factors for the stimulation of re-differentiation and cartilage formation have been tested to improve the quality of osteo-
chondral implants. It has been demonstrated that supplementation of the medium with growth factors has significant ef-
fects on the properties of the matrix. The addition of the growth factors IGF-I (100 ng/mL) and TGF-1 (10 ng/mL) dur-
ing the alginate culture and the absence of any growth factors during the high-density cell culture led to significantly 
higher GAG to DNA ratios and Young’s Moduli of the constructs compared to other combinations. The histological sec-
tions showed homogenous tissue and intensive staining for collagen type II. 
Keywords: Cartilage, osteochondral implants, growth factors, IGF-I, TGF-1, re-differentiation. 
INTRODUCTION  
  Full-thickness cartilage defects of the knee joint lead to 
pain and restriction in movement. Its treatment is still a 
common problem as existing therapies for the repair of ar-
ticular cartilage injuries do not offer complete restoration [1, 
2].  
  Methods of tissue engineering have opened up new 
strategies for the re-construction of cartilage. During the last 
years several approaches in cartilage tissue engineering have 
shown promising but not satisfying results which motivate 
for further studies [1-3]. In this work, osteochondral implants 
which consist of a ceramic carrier as bone substitute and a 
layer of cultivated cartilage are generated in vitro. A mosaic-
like implantation [2, 4] of these autologous cartilage-carrier-
constructs may provide a reconstructed surface area inside 
the knee joint. The cultivation principle includes the follow-
ing steps [5, 6]: (a) explanted chondrocytes are expanded in 
monolayer culture until passage 3; (b) afterwards the cells 
are seeded onto a solid carrier (cell coating) and cultivated 
for two weeks; (c) simultaneously expanded chondrocytes 
are suspended in alginate gel for two weeks to induce re-
differentiation; (d) the re-differentiated chondrocytes are 
then eluted out of the alginate gel and sedimented on the cell 
coated carrier. These cartilage-carrier-constructs are culti-
vated for cartilage formation for three weeks (high-density 
cell culture). The concept was applied successfully in mini-
pigs [7].  
  The initial cell number for the generation of autologous 
implants is limited by the small size of a biopsy which is 
assumed to count 0.2x10
6 to 1.2x10
6 cells. Hence, chondro-
cytes have to be expanded until the required cell number is 
reached; for example, for cartilage-carrier-constructs as per 
the presented method, with an initial cell number of 1x10
6 
cells it is necessary to subcultivate monolayer cultures until  
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passage 3 in order to fill an area of approximately 6 cm
2 in 
the joint. But, proliferation is accompanied by de-
differentiation of cells. De-differentiated chondrocytes stop 
production of cartilage-specific extracellular matrix compo-
nents, especially collagen type II and glycosaminoglycans, 
and acquire fibroblast-like morphology [8, 9]. To undergo 
chondrogenesis, cells have to re-differentiate, which is still 
under investigation in vitro. Re-differentiation can be sup-
ported by the addition of certain growth factors to the culture 
medium [9-11].  
  Research being carried out to determine the characteris-
tics and effects of growth factors in cartilage tissue engineer-
ing has proved that IGF-I (Insulin-like Growth Factor I) es-
pecially and TGF-1 (Transforming Growth Factor 1) de-
livered positive results. Both growth factors, IGF-I and TGF-
1, can be produced by chondrocytes and are accumulated in 
the extracellular matrix as a complex with binding proteins 
(IGF-I) or in a latent form (TGF-1) respectively [12]. In 
vivo, for instance, IGF-I expression is increased during heal-
ing of full-thickness cartilage defects [13] and  TGF-1 is 
present in tissues during differentiation [14]. From several 
studies, it is known that IGF-I and TGF-1 influence differ-
entiation of chondrocytes and cartilage formation in vitro as 
well. The varying results concerning the effects of these 
growth factors are attributed to the differences in culture 
conditions, species and age of donors, growth factor concen-
trations, status of cell differentiation or the addition of serum 
[15, 16]. To summarize, IGF-I is an important anabolic fac-
tor for chondrocytes and in vitro engineered cartilage. It can 
stimulate the proliferation of cells and extracellular matrix 
biosynthesis, in particular the production of proteoglycans 
[8, 11, 16, 17]. The addition of TGF-1 to the culture me-
dium has shown diverse effects on the cultivation of chon-
drocytes. It can stimulate or inhibit the cell growth and ac-
cumulation of proteoglycans and collagen type II [11]. Tsu-
kazaki et al. observed that TGF-1 acts synergistically with 
IGF-I, which means that a combination of both growth fac-
tors can influence the cultivation in a different way than can 
each growth factor alone [12, 16]. 86    The Open Biomedical Engineering Journal, 2007, Volume 1    Wiegandt et al. 
  Thus, growth factor supplements can improve the quality 
of engineered cartilage, but they have to be adjusted for each 
application in tissue engineering. In the current study, the 
effects of IGF-I and TGF-1 were examined during the re-
differentiation in alginate beads (step c) and cartilage forma-
tion in high-density cell cultures (step d) for the cultivation 
principle introduced above in order to optimize the bio-
chemical and biomechanical properties of the cartilage-
carrier-constructs in vitro. Porcine chondrocytes were used 
as an animal model system as animal experiments have to 
precede later clinical applications.  
MATERIALS AND METHODS 
Culture Procedure for Generation of Cartilage-Carrier-
Constructs 
  Porcine chrondrocytes were isolated from a knee joint of 
an approximately 5 month old domestic pig. Small pieces of 
cartilage were taken from femur and digested with hyaluron-
idase type III-solution (0.5 mg/mL, Sigma-Aldich, Germany) 
and with trypsin/EDTA-solution (PAA, Germany). The carti-
lage was further treated with collagenase type Ia-solution 
(0.5 mg/mL, Sigma-Aldrich) overnight. 
  Cells were cultured in T-flasks (Roth, Germany) until 
passage 3. The initial cell number was 2x10
5 cells for the 
generation of six constructs. Proliferation of the cells was 
performed in DMEM (Dulbecco`s Modified Eagle Medium, 
PAA) supplemented with 10% (v/v) fetal calf serum (FCS, 
PAA), penicillin/streptomycin (100 U/mL penicillin and 100 
g/mL streptomycin, PAA) and 10 ng/mL human basic Fi-
broblast Growth Factor (bFGF, CellConcepts, Germany) 
[18].  
  Cartilage-carrier-constructs were generated according to 
the concept described above  [6]. Briefly, after harvesting 
cells from the T-flasks, 2x10
5 chondrocytes were sedimented 
onto a calcium-phosphate-carrier (diameter 4.55 mm, Spon-
ceram HA
®, Zellwerk, Germany) to form a cell layer. During 
the cultivation of the cell layer, the above mentioned me-
dium was used to stimulate cell proliferation [18].  
  In parallel, chondrocytes from the same preculture were 
encapsulated in alginate beads (1x10
6 cells per mL alginate, 
Sigma-Aldrich) and cultivated for two weeks. Afterwards, 
the cells were recovered from the gel by using citrate buffer 
and centrifuged onto the cell coated carrier (1.8x10
6 cells per 
carrier).  
  The cartilage-carrier-constructs were then cultivated for 
three weeks in a high-density cell culture. During the re-
differentiation in alginate beads and the following cartilage 
formation of the cartilage-carrier-constructs, DMEM (PAA) 
supplemented with 10% (v/v) porcine serum (PS, Gibco, 
Germany), penicillin/streptomycin (100 U/mL penicillin and 
100 g/mL streptomycin, PAA), 0.28 mM L-ascorbic acid 2-
phosphate and 1 mM cysteine (Sigma-Aldrich) was used. 
Furthermore, different growth factors were added to the me-
dium. The medium was exchanged three times a week. 
  All cultivations were performed under an atmosphere of 
5% (v/v) O2 and 5% (v/v) CO2. 
Variation of Growth Factor Combination 
  To support re-differentiation in alginate gel and cartilage 
formation of cartilage-carrier-constructs, different growth 
factor combinations were tested. hIGF-I (100 ng/mL human 
IGF-I, Cell Concepts, Germany) or/and hTGF-1 (10 ng/mL 
human TGF-1, Cell Concepts) were added to the medium 
[Goepfert, unpublished].  
Table 1.  Experimental Set-Up 
No.  Alginate Gel  Cartilage Formation 
1.  100 ng/mL hIGF-I 
2. 
Without growth factors 
Without growth factors 
3.  100 ng/mL hIGF-I 
4. 
100 ng/mL hIGF-I 
Without growth factors 
5.  100 ng/mL hIGF-I 
6. 
100 ng/mL hIGF-I & 
10 ng/mL hTGF-1  Without growth factors 
 
  In the alginate gel, the cells were cultured either without 
any growth factors, with hIGF-I or with hIGF-I and hTGF-
1 at the same time. hTGF-1 alone was not used as prelimi-
nary tests showed a strong decrease in the production of car-
tilage-specific matrix components like collagen type II and 
glycosaminoglycans (unpublished data of the authors). Af-
terwards, during the cartilage formation, the cartilage-
carrier-constructs were cultivated with hIGF-I or without any 
growth factors. The different combinations are listed in Ta-
ble 1. For each combination, six constructs were prepared. 
Biochemical Analysis 
  To analyze biochemical properties of the extracellular 
matrix, glycosaminoglycan (GAG) content and amount of 
DNA were determined. The method is based on a work by 
Buschmann et al. [19]. Cartilage tissue was digested enzy-
matically with papain (Roche, Germany). The GAG content 
was then determined by staining with 1,9-dimethylene blue 
chloride (Serva, Germany) with chondroitin sulfate (Sigma-
Aldrich) as the standard and the DNA content using the fluo-
rescence marker H33258 (Sanofi-Aventis, Germany) with 
calf thymus DNA as the standard (for details see [5, 6]). 
Immunochemical Analysis 
  To determine the state of re-differentiation of cells after 
alginate culture, the recovered chondrocytes were centri-
fuged onto object slides (Histo-Bond, Marienfeldt, Germany) 
and then immunostained against collagen type I and collagen 
type II [20]. In the first step, monoclonal antibodies of mice 
(Acris Antibodies, Germany) were found to bind specifically 
to collagen type I (clone I-8H5) or collagen type II (clone II-
4C11). Afterwards, a secondary fluorescent antibody (Goat 
anti-mouse, [IgG (H+L), FITC], Southern Biotech, USA) 
was used for staining. The staining of the nuclei was per-
formed with DNA-binding fluorochrome 4-6-diamidino-2-
phenyl-di-hydro-chloride (Dapi, Sigma-Aldrich). The total 
amount of cells and the amount of cells generating collagen 
were analyzed using a fluorescence microscope (Nikon, 
Germany) and the corresponding software NIS Elements 
AR. Improving In Vitro Generated Cartilage-Carrier-Constructs  The Open Biomedical Engineering Journal, 2007, Volume 1    87 
  To determine the collagen type I and II formation of car-
tilage-carrier-constructs, the generated tissue was embedded 
in paraffin and 5 m thick histological sections were pre-
pared with a microtome (Leica, Germany). The histological 
sections were immunostained separately with primary anti-
bodies (Acris Antibodies) against collagen type I and colla-
gen type II. As the secondary antibody, a biotinylated anti-
body (Goat anti-mouse, [IgG (H+L)-biotin], Southern Bio-
tech) was used. Color development was carried out using 
strepatividin/alkaline phosphatase complex (Linaris, Ger-
many) and the New Fuchsin chromogen (Sigma-Aldrich) 
[20]. Nuclei were stained with haematoxilin (Roth). 
Biomechanical Parameters 
  At the end of each cultivation, the wet weight (Mettler 
AE200, Germany), the height and the Young’s Modulus of 
the cartilage-constructs were measured. For determination of 
the height and the Young’s Modulus, a high-precision mate-
rial testing machine (Zwicki 1120, Zwick, Germany) was 
used. For the determination of the Young’s Modulus step-
wise stress-relaxation tests (five steps with 4% of the un-
compressed cartilage thickness each) were carried out ac-
cording to Korhonen et al. [21]. The criterion for relaxation 
was a relaxation rate of less than 0.002 N/min. The Young’s 
Modulus was calculated from resulting stress-strain curve. 
Statistics 
Statistics software NCSS97 was applied to evaluate statisti-
cal significance of the data (p < 0.05, ANOVA). 
RESULTS 
Alginate Culture 
  In order to evaluate re-differentiation after recovering 
cells from the alginate gel, the GAG to DNA ratio and the 
percentage of collagen type I and collagen type II producing 
cells were determined.  
 Fig.  (1) shows that the absence of any growth factors 
during the alginate culture resulted in fewer collagen type I 
and collagen type II producing cells compared to the other 
supplementations. Not only the percentage of collagen type 
II producing cells in the cultures using IGF-I or IGF-I and 
TGF-1 rose to nearly 100%, but also an increase of colla-
gen type I could be determined.  
 
 
 
 
 
 
 
 
 
Fig. (1). Biochemical parameters GAG to DNA ratio and collagen 
type I and collagen type II producing cells of the alginate culture, 
either without any growth factors, with IGF-I or IGF-I and TGF-1 
(n=4, standard deviation of the mean, * significantly lowest GAG to 
DNA ratio). 
  The significantly lowest GAG to DNA ratios were found 
during the cultivation with IGF-I and TGF-1. Compared to 
this, the other conditions led to relatively high GAG to DNA 
ratios of more than 40 g/g. 
Cartilage-Carrier-Constructs 
  The absence of any growth factors (w/o GF) during the 
alginate culture led to irregularly shaped cartilage-carrier-
constructs (Fig. 2/1, 2/2). Using only IGF-I during cultiva-
tion in alginate beads resulted in very soft and unstable carti-
lage. In Fig. 2, it is visible that these constructs (Fig. 2/3, 
2/4) consist of only small amounts of tissue on top of the 
carrier. Because of the low height of these constructs a bio-
chemical and biomechanical analysis was not possible and 
only the other combinations were considered for further 
studies (Fig. 2/1, 2/2, 2/5, 2/6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Top view of cartilage-carrier-constructs (1) alginate gel: 
w/o GF, cartilage formation: IGF-I; (2) alginate gel: w/o GF, carti-
lage formation: w/o GF; (3) alginate gel: IGF-I, cartilage formation: 
IGF-I; (4) alginate gel: IGF-I, cartilage formation: w/o GF; (5) algi-
nate gel: IGF-I&TGF-1, cartilage formation: IGF-I; (6) alginate 
gel: IGF-I&TGF-1, cartilage formation: w/o GF; (scale bar= 1 
mm). 
  The largest constructs were found for the supplementa-
tion with IGF-I and TGF-1 during the alginate culture and 
IGF-I during the cartilage formation. These observations 
were also confirmed by the data obtained for the wet weight 
and height of the engineered cartilage presented (data in Fig. 
3). Comparing the biomechanical parameters showed that the 
constructs cultivated with IGF-I and TGF-1 during the algi-
nate culture and without any growth factors during the carti-
lage formation exhibited the significantly highest Young’s 
Modulus of 0.0595 MPa.  
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Fig. (3). Biomechanical parameters weight, height and Young’s 
Modulus of cartilage-carrier-constructs cultivated with different 
growth factor combinations (A - alginate culture, C - cartilage for-
mation; n=6, standard deviation of the mean, significances not 
shown). 
 
 
 
 
 
 
 
 
 
Fig. (4). Relationship between GAG- and DNA-content of carti-
lage-carrier-constructs cultivated with different growth factor com-
binations (A - alginate culture, C -cartilage formation; n=6, stan-
dard deviation of the mean, significances not shown). 
  The DNA concentration of cartilage-carrier-constructs 
cultured without any growth factors during cartilage forma-
tion was nearly twice as high as those using growth factors 
(Fig. 4). However, the GAG fraction of constructs is a more 
relevant factor for evaluation of cartilage as it influences the 
biomechanical properties of tissue [22].  It increased when 
IGF-I and TGF-1 were used during the alginate culture. 
Fig. 4 shows the significantly highest GAG to DNA ratio of 
116 g/g for the constructs cultivated with IGF-I and TGF-
1 during alginate culture and with IGF-I during cartilage 
formation. 
  The immunohistological images (Fig. 5) show a more 
prominent staining for collagen type II than for collagen type 
I in all cases. When cultivations were performed without any 
growth factors during the alginate culture, the constructs 
showed a tissue interspersed with holes. In contrast, the cul-
tivation with IGF-I and TGF-1 resulted in homogenous 
tissue in which chondrocytes were evenly distributed. 
DISCUSSION 
  One approach for the treatment of full-thickness cartilage 
defects is the generation of autologous osteochondral im-
plants with the aid of tissue engineering methods. To mini-
mize the donor site morbidity due to a biopsy, it is necessary 
to expand the chondrocytes [8], which leads to a de-
differentiation of the cells. It is possible to induce re-
differentiation by three-dimensional cultivation and the addi-
tion of growth factors. Many studies have demonstrated 
positive effects of the growth factors IGF-I and TGF-1 [9-
11, 16, 17]. The present work was designed to determine an 
optimal combination of growth factor supplementation for 
our cultivation principle and thereby to improve the cartilage 
formation. Therefore, the expanded cells were first re-
differentiated in an alginate gel and then further cultivated as 
cartilage-carrier-constructs for three weeks. Different com-
binations (Table 1) of the growth factors IGF-I and TGF-1 
were tested during the re-differentiation in alginate beads 
and afterwards during the cartilage formation of the con-
structs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Immunohistological staining: left column for collagen type 
I, right column for collagen type II (1a)/(1b) alginate gel: w/o GF, 
cartilage formation: IGF-I; (2a)/(2b) alginate gel: w/o GF, cartilage 
formation: w/o GF; (5a)/(5b) alginate gel: IGF-I&TGF-1, cartilage 
formation: IGF-I; (6a)/(6b) alginate gel: IGF-I&TGF-1, cartilage 
formation: w/o GF; condition 3 and 4 not shown (scale bar= 100 
m) 
  In this work, it is shown that it is not suitable to investi-
gate the phases of the cultivation principle separately as the 
different steps are influenced by each other. Furthermore, it 
can be concluded that chondrocytes react in a different way 
to certain growth factors during re-differentiation or cartilage 
formation. 
  The absence of any growth factors during the cultivation 
in alginate gel resulted in a high GAG to DNA ratio of 40.1 
g/g, but the number of cells which produced collagen type 
II were fewer than the cells cultured with IGF-I or IGF-I and 
TGF-1. Collagen type II is an important extracellular ma-
trix component, while collagen type I is generally not present 
in articular cartilage [8]. Hence, these results demonstrate 
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that the investigated growth factors can support the re-
differentiation, here identified by the collagen type II pro-
duction [9-11, 16, 17]. The generated constructs using no 
growth factors during alginate culture showed an irregular 
shape and tissue interspersed with holes.  
Table  2.  Summary of biochemical and biomechanical pa-
rameters of the generated cartilage-carrier-
constructs (1.) alginate gel: w/o GF, cartilage forma-
tion: IGF-I; (2.) alginate gel: w/o GF, cartilage for-
mation: w/o GF; (5.) alginate gel: IGF-I &TGF-1, 
cartilage formation: IGF-I; (6.) alginate gel: IGF-I 
&TGF-1, cartilage formation: w/o GF; condition 3. 
and 4. not shown 
Condition  1. 2. 5. 6. 
Height 
[mm] 
1.07 
±0.13 
0.44 
±0.04 
1.24 
±0.01 
1.47 
±0.02 
Wet weight 
[mg] 
56.28 
±15.0 
24.68 
±3.64 
76.89 
±13.0 
44.8 
±7.51 
Young’s Modulus 
[MPa] 
0.0098 
±0.003 
0.0064 
±0.001 
0.0357 
±0.001 
0.0595 
±0.013 
DNA 
[g/mgcartilage] 
0.174 
±0.015 
0.338 
±0.125 
0.180 
±0.023 
0.286 
±0.018 
GAG 
[g/mgcartilage] 
9.78 
±1.27 
8.35 
±1.58 
20.56 
±2.12 
21.85 
±2.84 
GAG/DNA 
[g/g] 
56.62 
±6.63 
26.57 
±6.97 
116.09 
±15.43 
76.88 
±8.57 
 
  The analysis of the alginate cultures led to the assump-
tion that cells cultivated with IGF-I result in constructs with 
improved matrix properties  compared to the cultivation 
without any growth factors or with IGF-I and TGF-1. Fig. 1 
shows a GAG to DNA ratio of 44.4 g/g and a collagen 
type II to I ratio of 1.06. Nearly 100 % of the cells produced 
the cartilage-specific collagen type II, but unfortunately also 
collagen type I. However, the resulting tissue was soft and 
no stable cartilage-carrier-constructs could be prepared from 
it. It is assumed that the cells have been stimulated by IGF-I 
to produce large amounts of proteoglycans. This presump-
tion corresponds to the findings of many other groups [8, 11, 
12]. But possibly, the collagen network did not develop ade-
quately to maintain the cells as a pellet. These data demon-
strate that the production of large amounts of proteoglycans 
during the alginate culture does not necessarily lead to the 
formation of high quality cartilage. Thus, addition of IGF-I 
during the alginate culture is not sufficient for our applica-
tion.  
  The GAG to DNA ratio after the alginate culture using 
IGF-I and TGF-1 was only 15.7 g/g which is signifi-
cantly lower than the other combinations. During their stud-
ies, Blunk et al. [11] also found, compared to the standard 
conditions, a decrease of the glycosaminoglycan fraction, 
when bovine calf chondrocytes were cultivated with IGF-I 
and TGF-1 on polyglycolic acid scaffolds. Nevertheless, 
when using IGF-I and TGF-1 during the alginate culture 
resulted in constructs with the highest biochemical and 
biomechanical properties compared to the other conditions in 
our work. 
 Table  2 shows a summary of the biochemical and biome-
chanical parameters of the generated cartilage-carrier-
constructs. Constructs which were cultivated first with IGF-I 
and TGF-1 and afterwards during the cartilage formation 
with IGF-I yielded the significantly highest GAG to DNA 
ratio of 116.1 g/g, which is already 70 % of that of native 
cartilage. In contrast, the significantly highest Young’s 
Modulus was observed for the constructs which were culti-
vated with IGF-I and TGF-1 during the re-differentiation in 
alginate beads and without any growth factors during the 
cartilage formation. The Young’s Modulus achieved (0.0595 
MPa) was only 15 % of that of native cartilage. For both 
conditions, histological sections showed homogenous tissue 
with an intensive staining against collagen type II. Accord-
ing to the presented results, the biochemical appearance of 
the tissue engineered cartilage is close to native cartilage, 
while it is still necessary to improve the biomechanical prop-
erties.  
 Articular  cartilage  in vivo has to transmit high stress [13]. 
Thus, it is important that tissue engineered cartilage can 
withstand these loadings. Because the Young’s Modulus is 
an indicator for the stiffness of the extracellular matrix, we 
decided to proceed with our research using IGF-I and TGF-
1 as medium supplements during the re-differentiation in 
alginate beads and no growth factors during the cartilage 
formation in high-density cell cultures. During cultivation in 
vitro biomechanical parameters may be increased by me-
chanical load like hydrostatic pressure, direct compression or 
shear stress. From several studies it is known that these me-
chanical stimuli influence the production and organization of 
cartilage-specific matrix components [23, 24]. 
CONCLUSION 
  In this study, it was shown that the addition of certain 
growth factors during the generation of osteochondral im-
plants had significant effects on the properties of the matrix. 
We were able to determine the required optimal growth fac-
tor combinations during the different steps of the presented 
cultivation scheme, which support the re-differentiation and 
cartilage formation in vitro and thereby improve the biome-
chanical and biochemical properties of porcine cartilage-
carrier-constructs. It is still required to further increase frac-
tions of extracellular matrix, especially collagen type II, and 
to improve the biophysical parameters. In addition, it is 
needed to investigate an effective growth factor combination 
for adult human chondrocytes.  
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